.Pharmacolibrary.Drugs.ATC.N.N05AH02 .Pharmacolibrary.Drugs.ATC.N.N05AH02| name: | Clozapine |
| ATC code: | N05AH02 | route: | oral |
| n-compartments | 2 |
Clozapine is an atypical antipsychotic medication primarily used for treatment-resistant schizophrenia. It is known for its effectiveness in patients unresponsive to other antipsychotics but is associated with risks such as agranulocytosis and requires regular blood monitoring. Clozapine is approved and in clinical use today.
Typical pharmacokinetic parameters modelled in adult patients with schizophrenia (mixed sex, oral administration).
Jerling, M, et al., & Mallet, A (1997). Population pharmacokinetics of clozapine evaluated with the nonparametric maximum likelihood method. British journal of clinical pharmacology 44(5) 447–453. DOI:10.1046/j.1365-2125.1997.t01-1-00606.x PUBMED:https://pubmed.ncbi.nlm.nih.gov/9384461
Simon, N, et al., & Azorin, JM (2022). Comorbidities and the right dose: antipsychotics. Expert opinion on drug metabolism & toxicology 18(7-8) 507–518. DOI:10.1080/17425255.2022.2113378 PUBMED:https://pubmed.ncbi.nlm.nih.gov/35979611
Qiu, XW, et al., & Lu, W (2009). [Population pharmacokinetics research of clozapine in Chinese schizophrenic patients]. Yao xue xue bao = Acta pharmaceutica Sinica 44(7) 785–792. PUBMED:https://pubmed.ncbi.nlm.nih.gov/19806921